The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases.

Rui KitadaiYusuke OkumaTaiki HakozakiYukio Hosomi

Published in: Journal of cancer research and clinical oncology (2019)

Despite the poor outcomes with ICI treatment in patients with advanced and recurrent NSCLC who had liver metastasis, some characteristics among patients with liver metastasis may be associated with prognosis.

Keyphrases

advanced non small cell lung cancer
liver metastases
epidermal growth factor receptor
small cell lung cancer
type diabetes
adipose tissue
insulin resistance